<a href='https://brc.riken.jp/mus/pcr01725'>Genotyping protocol -PCR-</a>
国立大学法人京都大学
長田 重一
開発年:2001年 開発者:長田重一先生・川根公樹先生ら、 機関名:大阪大学大学院生命機能研究科 129Sv の ES 細胞を用いて作成した DNase II 遺伝子欠損マウス C57BL/6に対して6回の戻し交配を行った。
B6;129-Dnase2a<tm1Osa>. In macrophage, DNase II, deoxyribonuclease II is responsible for digesting nuclear DNA expelled from erythroid precuursor cells. Homozygous null mice for DNase II are embryonic lethal due to sever anemia, and impaired definitive erythropoiesis in the fetal liver. This strain is useful for elucidation of the function of DNase II gene.
C(3〜6か月)
DNase II Hetero; DNase II Hetero Knockout mouse
ホモは耐性致死であることから、ヘテロで維持。
Shigekazu NAGATA
Developed by Drs. Kohki Kawane and Shigekazu Nagata at Osaka University in 2001. A neomycin cassette replaced exons 1-5 and part of 6 of the Dnase2a gene. The mutant mice were backcrossed to C57BL/6.
Mouse Models for Human Disease
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Science, 292, 1546-1549 (2001).RECIPIENT may only use the BIOLOGICAL RESOURCE for non-commercial academic research purpose.<br>The RECIPIENT should negotiate with the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE.<br>For period of two (2) years after deposition by the DEPOSITOR to the REKEN BRC, the RECIPIENT agrees to include the DEPOSITOR/DEVELOPER as a co-author.
mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse Dnase2a genomic DNA, Phage P1 loxP site [update May 21, 2015]
Kyoto Univ.
R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>]
RBRC01725
開発年:2001年開発者:長田重一先生・川根公樹先生ら、機関名:大阪大学大学院生命機能研究科129Sv の ES 細胞を用いて作成した DNase II 遺伝子欠損マウスC57BL/6に対して6回の戻し交配を行った。
true
Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="http://biochemi.ifrec.osaka-u.ac.jp/english/" target="_blank">Lab HP</A>
C (3-6 months)
条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Science, 292, 1546-1549 (2001).<br>公表を前提とした学術研究に限る。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請及び事業活動を行う場合は寄託者と別途協議を行う。利用者が本件リソース寄託後2年以内に理研BRCより提供を受けて得た研究成果の発表は寄託者(開発者)との共著とする。
DNase II 遺伝子 (Gene ID = 13423) のエクソン1〜6をネオマイシン耐性遺伝子に置換したマウス
DNase II へテロ; DNase II Hetero Knockout mouse
Backcross to C57BL/6 (Heterozygote x C57BL/6NCrlCrlj)
B6;129-Dnase2a<tm1Osa>/OsaRbrc
B6;129-Dnase2a<tm1Osa>/OsaRbrc